Limited knowledge on progestogen-only contraception and risk of venous thromboembolism

Objective. To assess the current knowledge concerning progestogen-only contraception (POC) and risks of venous thromboembolism (VTE). Design and setting. Systematic review of the literature on observational and analytical studies reporting risk estimates for VTE in women exposed to POCs. Methods and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta obstetricia et gynecologica Scandinavica 2009-01, Vol.88 (3), p.261-266
Hauptverfasser: Bergendal, Annica, Odlind, Viveca, Persson, Ingemar, Kieler, Helle
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 266
container_issue 3
container_start_page 261
container_title Acta obstetricia et gynecologica Scandinavica
container_volume 88
creator Bergendal, Annica
Odlind, Viveca
Persson, Ingemar
Kieler, Helle
description Objective. To assess the current knowledge concerning progestogen-only contraception (POC) and risks of venous thromboembolism (VTE). Design and setting. Systematic review of the literature on observational and analytical studies reporting risk estimates for VTE in women exposed to POCs. Methods and main outcome measures. We performed a computerized literature search in the Pub Med, Embase, and the Cochrane Library for studies published between 1966 and February 13, 2008. Based on the evaluated studies we calculated an overall risk estimate for VTE in association with POC. Results. Four case-control studies and one cohort study were included. Of the case-control studies, three reported an increased risk and one a decreased risk of VTE. The cohort study found divergent results depending on the type of statistical analysis used. None of the results was statistically significant. The overall odds ratio for POC-associated VTE in the four case-control studies was 1.45 (95% CI=0.92-2.26). Conclusions. The risk of VTE associated with use of POCs is poorly investigated. The slightly elevated overall risk estimate might suggest an association between POC and an increased risk for VTE. The results must, however, be interpreted with caution due to the possibility of residual confounding. Well-designed studies with sufficient statistical power to evaluate risks of VTE with POC are warranted.
doi_str_mv 10.1080/00016340902730375
format Article
fullrecord <record><control><sourceid>istex_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_560056</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ark_67375_WNG_36FS53DQ_3</sourcerecordid><originalsourceid>FETCH-LOGICAL-c6581-7edb2db32aa1d2613d9063f77024885cac27e22f877b28d28ffc2844a150a9f43</originalsourceid><addsrcrecordid>eNqFkcuO0zAYRi0EYsrAA7BB2bAj4FtiR6yqGaYgVYwQMCwtx5fW08Su7ITSt8dVQ7tAAwvfz7Hl_wPgJYJvEeTwHYQQ1YTCBmJGIGHVIzBDNYQlpAg_BrPDeZmB5gI8S-k-rzCj_Cm4QA1imGI8A3dL17vB6GLjw64zemWK4IttDCuThtz5MvhuX6jghyiV2Q4uH0uvi-jSpgi2-Gl8GFMxrGPo22By61zqn4MnVnbJvJjGS_D95sO3q4_l8nbx6Wq-LFVdcVQyo1usW4KlRBrXiOgG1sQyBjHlvFJSYWYwtpyxFnONubUKc0olqqBsLCWXoDzem3ZmO7ZiG10v414E6cS0tckzI6pclqrOfPMgnz-tz9IfESFOKkQrlt03D7rX7m4uQlyJcRSI5jh4xtERVzGkFI09CQiKQ3zir_iy8-ro5Pt7o8_GlFcGXk-ATEp2NkqvXDpxGGHIED7UpTpyO9eZ_f9fFvPbBW_QuZ4uDebXyZNxI2p24H58XghS33ytyPUXQTL_fuK9DbGXayO7Ya1kNOI-jNHn7P_x3d_mxdR1</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Limited knowledge on progestogen-only contraception and risk of venous thromboembolism</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Bergendal, Annica ; Odlind, Viveca ; Persson, Ingemar ; Kieler, Helle</creator><creatorcontrib>Bergendal, Annica ; Odlind, Viveca ; Persson, Ingemar ; Kieler, Helle</creatorcontrib><description>Objective. To assess the current knowledge concerning progestogen-only contraception (POC) and risks of venous thromboembolism (VTE). Design and setting. Systematic review of the literature on observational and analytical studies reporting risk estimates for VTE in women exposed to POCs. Methods and main outcome measures. We performed a computerized literature search in the Pub Med, Embase, and the Cochrane Library for studies published between 1966 and February 13, 2008. Based on the evaluated studies we calculated an overall risk estimate for VTE in association with POC. Results. Four case-control studies and one cohort study were included. Of the case-control studies, three reported an increased risk and one a decreased risk of VTE. The cohort study found divergent results depending on the type of statistical analysis used. None of the results was statistically significant. The overall odds ratio for POC-associated VTE in the four case-control studies was 1.45 (95% CI=0.92-2.26). Conclusions. The risk of VTE associated with use of POCs is poorly investigated. The slightly elevated overall risk estimate might suggest an association between POC and an increased risk for VTE. The results must, however, be interpreted with caution due to the possibility of residual confounding. Well-designed studies with sufficient statistical power to evaluate risks of VTE with POC are warranted.</description><identifier>ISSN: 0001-6349</identifier><identifier>ISSN: 1600-0412</identifier><identifier>EISSN: 1600-0412</identifier><identifier>DOI: 10.1080/00016340902730375</identifier><identifier>PMID: 19172422</identifier><identifier>CODEN: AOGSAE</identifier><language>eng</language><publisher>Oxford, UK: Informa UK Ltd</publisher><subject>Biological and medical sciences ; Blood and lymphatic vessels ; Cardiology. Vascular system ; Case-Control Studies ; Cohort Studies ; Contraceptives, Oral, Hormonal - adverse effects ; Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous ; epidemiology ; Female ; Gynecology. Andrology. Obstetrics ; Humans ; Medical sciences ; MEDICIN ; Medicin och hälsovetenskap ; MEDICINE ; observational studies ; Odds Ratio ; Progestins - administration &amp; dosage ; Progestins - adverse effects ; Progestogen-only contraception ; Risk Assessment ; systematic review ; venous thromboembolism ; Venous Thromboembolism - chemically induced</subject><ispartof>Acta obstetricia et gynecologica Scandinavica, 2009-01, Vol.88 (3), p.261-266</ispartof><rights>2009 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2009</rights><rights>Acta Obstet Gynecol Scand 2009</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c6581-7edb2db32aa1d2613d9063f77024885cac27e22f877b28d28ffc2844a150a9f43</citedby><cites>FETCH-LOGICAL-c6581-7edb2db32aa1d2613d9063f77024885cac27e22f877b28d28ffc2844a150a9f43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1080%2F00016340902730375$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1080%2F00016340902730375$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1417,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21207124$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19172422$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-140278$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:118351457$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Bergendal, Annica</creatorcontrib><creatorcontrib>Odlind, Viveca</creatorcontrib><creatorcontrib>Persson, Ingemar</creatorcontrib><creatorcontrib>Kieler, Helle</creatorcontrib><title>Limited knowledge on progestogen-only contraception and risk of venous thromboembolism</title><title>Acta obstetricia et gynecologica Scandinavica</title><addtitle>Acta Obstet Gynecol Scand</addtitle><description>Objective. To assess the current knowledge concerning progestogen-only contraception (POC) and risks of venous thromboembolism (VTE). Design and setting. Systematic review of the literature on observational and analytical studies reporting risk estimates for VTE in women exposed to POCs. Methods and main outcome measures. We performed a computerized literature search in the Pub Med, Embase, and the Cochrane Library for studies published between 1966 and February 13, 2008. Based on the evaluated studies we calculated an overall risk estimate for VTE in association with POC. Results. Four case-control studies and one cohort study were included. Of the case-control studies, three reported an increased risk and one a decreased risk of VTE. The cohort study found divergent results depending on the type of statistical analysis used. None of the results was statistically significant. The overall odds ratio for POC-associated VTE in the four case-control studies was 1.45 (95% CI=0.92-2.26). Conclusions. The risk of VTE associated with use of POCs is poorly investigated. The slightly elevated overall risk estimate might suggest an association between POC and an increased risk for VTE. The results must, however, be interpreted with caution due to the possibility of residual confounding. Well-designed studies with sufficient statistical power to evaluate risks of VTE with POC are warranted.</description><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Cardiology. Vascular system</subject><subject>Case-Control Studies</subject><subject>Cohort Studies</subject><subject>Contraceptives, Oral, Hormonal - adverse effects</subject><subject>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</subject><subject>epidemiology</subject><subject>Female</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>MEDICIN</subject><subject>Medicin och hälsovetenskap</subject><subject>MEDICINE</subject><subject>observational studies</subject><subject>Odds Ratio</subject><subject>Progestins - administration &amp; dosage</subject><subject>Progestins - adverse effects</subject><subject>Progestogen-only contraception</subject><subject>Risk Assessment</subject><subject>systematic review</subject><subject>venous thromboembolism</subject><subject>Venous Thromboembolism - chemically induced</subject><issn>0001-6349</issn><issn>1600-0412</issn><issn>1600-0412</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcuO0zAYRi0EYsrAA7BB2bAj4FtiR6yqGaYgVYwQMCwtx5fW08Su7ITSt8dVQ7tAAwvfz7Hl_wPgJYJvEeTwHYQQ1YTCBmJGIGHVIzBDNYQlpAg_BrPDeZmB5gI8S-k-rzCj_Cm4QA1imGI8A3dL17vB6GLjw64zemWK4IttDCuThtz5MvhuX6jghyiV2Q4uH0uvi-jSpgi2-Gl8GFMxrGPo22By61zqn4MnVnbJvJjGS_D95sO3q4_l8nbx6Wq-LFVdcVQyo1usW4KlRBrXiOgG1sQyBjHlvFJSYWYwtpyxFnONubUKc0olqqBsLCWXoDzem3ZmO7ZiG10v414E6cS0tckzI6pclqrOfPMgnz-tz9IfESFOKkQrlt03D7rX7m4uQlyJcRSI5jh4xtERVzGkFI09CQiKQ3zir_iy8-ro5Pt7o8_GlFcGXk-ATEp2NkqvXDpxGGHIED7UpTpyO9eZ_f9fFvPbBW_QuZ4uDebXyZNxI2p24H58XghS33ytyPUXQTL_fuK9DbGXayO7Ya1kNOI-jNHn7P_x3d_mxdR1</recordid><startdate>20090101</startdate><enddate>20090101</enddate><creator>Bergendal, Annica</creator><creator>Odlind, Viveca</creator><creator>Persson, Ingemar</creator><creator>Kieler, Helle</creator><general>Informa UK Ltd</general><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>DF2</scope></search><sort><creationdate>20090101</creationdate><title>Limited knowledge on progestogen-only contraception and risk of venous thromboembolism</title><author>Bergendal, Annica ; Odlind, Viveca ; Persson, Ingemar ; Kieler, Helle</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c6581-7edb2db32aa1d2613d9063f77024885cac27e22f877b28d28ffc2844a150a9f43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Cardiology. Vascular system</topic><topic>Case-Control Studies</topic><topic>Cohort Studies</topic><topic>Contraceptives, Oral, Hormonal - adverse effects</topic><topic>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</topic><topic>epidemiology</topic><topic>Female</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>MEDICIN</topic><topic>Medicin och hälsovetenskap</topic><topic>MEDICINE</topic><topic>observational studies</topic><topic>Odds Ratio</topic><topic>Progestins - administration &amp; dosage</topic><topic>Progestins - adverse effects</topic><topic>Progestogen-only contraception</topic><topic>Risk Assessment</topic><topic>systematic review</topic><topic>venous thromboembolism</topic><topic>Venous Thromboembolism - chemically induced</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bergendal, Annica</creatorcontrib><creatorcontrib>Odlind, Viveca</creatorcontrib><creatorcontrib>Persson, Ingemar</creatorcontrib><creatorcontrib>Kieler, Helle</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Uppsala universitet</collection><jtitle>Acta obstetricia et gynecologica Scandinavica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bergendal, Annica</au><au>Odlind, Viveca</au><au>Persson, Ingemar</au><au>Kieler, Helle</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Limited knowledge on progestogen-only contraception and risk of venous thromboembolism</atitle><jtitle>Acta obstetricia et gynecologica Scandinavica</jtitle><addtitle>Acta Obstet Gynecol Scand</addtitle><date>2009-01-01</date><risdate>2009</risdate><volume>88</volume><issue>3</issue><spage>261</spage><epage>266</epage><pages>261-266</pages><issn>0001-6349</issn><issn>1600-0412</issn><eissn>1600-0412</eissn><coden>AOGSAE</coden><abstract>Objective. To assess the current knowledge concerning progestogen-only contraception (POC) and risks of venous thromboembolism (VTE). Design and setting. Systematic review of the literature on observational and analytical studies reporting risk estimates for VTE in women exposed to POCs. Methods and main outcome measures. We performed a computerized literature search in the Pub Med, Embase, and the Cochrane Library for studies published between 1966 and February 13, 2008. Based on the evaluated studies we calculated an overall risk estimate for VTE in association with POC. Results. Four case-control studies and one cohort study were included. Of the case-control studies, three reported an increased risk and one a decreased risk of VTE. The cohort study found divergent results depending on the type of statistical analysis used. None of the results was statistically significant. The overall odds ratio for POC-associated VTE in the four case-control studies was 1.45 (95% CI=0.92-2.26). Conclusions. The risk of VTE associated with use of POCs is poorly investigated. The slightly elevated overall risk estimate might suggest an association between POC and an increased risk for VTE. The results must, however, be interpreted with caution due to the possibility of residual confounding. Well-designed studies with sufficient statistical power to evaluate risks of VTE with POC are warranted.</abstract><cop>Oxford, UK</cop><pub>Informa UK Ltd</pub><pmid>19172422</pmid><doi>10.1080/00016340902730375</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0001-6349
ispartof Acta obstetricia et gynecologica Scandinavica, 2009-01, Vol.88 (3), p.261-266
issn 0001-6349
1600-0412
1600-0412
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_560056
source MEDLINE; Wiley Online Library All Journals
subjects Biological and medical sciences
Blood and lymphatic vessels
Cardiology. Vascular system
Case-Control Studies
Cohort Studies
Contraceptives, Oral, Hormonal - adverse effects
Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous
epidemiology
Female
Gynecology. Andrology. Obstetrics
Humans
Medical sciences
MEDICIN
Medicin och hälsovetenskap
MEDICINE
observational studies
Odds Ratio
Progestins - administration & dosage
Progestins - adverse effects
Progestogen-only contraception
Risk Assessment
systematic review
venous thromboembolism
Venous Thromboembolism - chemically induced
title Limited knowledge on progestogen-only contraception and risk of venous thromboembolism
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T13%3A36%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-istex_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Limited%20knowledge%20on%20progestogen-only%20contraception%20and%20risk%20of%20venous%20thromboembolism&rft.jtitle=Acta%20obstetricia%20et%20gynecologica%20Scandinavica&rft.au=Bergendal,%20Annica&rft.date=2009-01-01&rft.volume=88&rft.issue=3&rft.spage=261&rft.epage=266&rft.pages=261-266&rft.issn=0001-6349&rft.eissn=1600-0412&rft.coden=AOGSAE&rft_id=info:doi/10.1080/00016340902730375&rft_dat=%3Cistex_swepu%3Eark_67375_WNG_36FS53DQ_3%3C/istex_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/19172422&rfr_iscdi=true